Chevron Corporation vs ONEOK, Inc. — Stock Comparison
Q·Score Breakdown
6.4
Neutral
Overall
6.8
Neutral
Quality
Health
Growth
Valuation
Sentiment
CVX
Clean balance sheet with low leverage (0.2× debt-to-equity).
⚠ earnings contracting 44% year-over-year.
OKE
High-quality business with 16% return on equity and 10% profit margins.
⚠ balance sheet warrants attention.
Analyst Consensus
BUY
Target $213.30 (+11.9%)
23 analysts
HOLD
Target $94.67 (+4.8%)
21 analysts
Fundamentals
CVX
OKE
33.2×
Trailing P/E
16.1×
16.1×
Forward P/E
14.6×
5.9%
Profit Margin
10.0%
42.4%
Gross Margin
29.6%
—
ROE
15.9%
3.5%
Revenue Growth
19.6%
-44.4%
Earnings Growth
18.0%
0.59
Beta
0.81
—
Price / Book
—
$379.7B
Market Cap
$56.9B
$134 – $215
52-Week Range
$64 – $95
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →